The success of sleeve gastrectomy in the management of metabolic syndrome and obesity

Journal of Biomedical Research

Volumn 29, Issue 2, 2015, Pages 93-97

  Shabbir, Asim ^a   Dargan, Dallan ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Diabetes mellitus; Metabolic surgery; Obesity; Sleeve gastrectomy

Indexed keywords

BILIOPANCREATIC BYPASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; FOOD; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LAPAROSCOPIC SURGERY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; SLEEVE GASTRECTOMY; SPECIALIZATION; SURGEON; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84933056195     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20140107     Document Type: Review

References (34)

1. Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19):2486.
2. Lakdawala M, Bhasker A. Report: Asian consensus meeting on metabolic surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population. Obes Surg 2010;20(7):929-936.
3. Lomanto D, Lee W-J, Goel R, et al. Bariatric surgery in Asia in the last 5 years (2005-2009). Obes Surg 2012;22(3):502-506.
4. de Imprensa S, SBCBM N. Bariatric Surgical and Procedural Interventions in the Treatment of Obese Patients with Type 2 Diabetes.
5. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009;150(6):2518-2525.
6. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244(5):741.
7. Lee W-J, Chen C-Y, Chong K, et al. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011;7(6):683-690.
8. Jorgensen NB, Dirksen C, Bojsen-Moller KN, et al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 2013;62(9):3044-52.
9. Basso N, Capoccia D, Rizzello M, et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 2011;25(11):3540-3550.
10. Melissas J, Daskalakis M. Gastric emptying after sleeve gastrectomy. Obes Surg 2011;21(11):1810-1811.
11. Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy-a restrictive procedure? Obes Surg 2007;17(1):57-62.
12. Tzovaras G, Papamargaritis D, Sioka E, et al. Symptoms suggestive of dumping syndrome after provocation in patients after laparoscopic sleeve gastrectomy. Obes Surg 2012;22(1):23-28.
13. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008;247(3):401-407.
14. Bohdjalian A, Langer F, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010;20(5):535-540.
15. Gagner M, Deitel M, Erickson A, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg 2013;23(12):2013-2017.
16. Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 2010;252(2):319-324.
17. Eid GM, Brethauer S, Mattar SG, et al. Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93% follow-up. Ann Surg 2012;256(2):262-265.
18. Parikh M, Issa R, McCrillis A, et al. Surgical strategies that may decrease leak after laparoscopic sleeve gastrectomy: a systematic review and meta-analysis of 9991 cases. Ann Surg 2013;257(2):231-237.
19. Kashyap SR, Bhatt DL, Schauer PR, et al. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes, Obesity and Metabolism 2010;12(5):452-454.
20. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366(17):1567-1576.
21. Sarkhosh K, Birch DW, Shi X, et al. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg 2012;22(5):832-837.
22. Cavarretta E, Casella G, Cal B, et al. Cardiac remodeling in obese patients after laparoscopic sleeve gastrectomy. World J Surg 2013;37(3):565-572.
23. Zhang F, Strain GW, Lei W, et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg 2011;21(3):305-309.
24. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010;147(5):664-669.
25. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013;36(8):2175-2182.
26. Wang S, Li P, Sun XF, et al. Comparison between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding for morbid obesity: a meta-analysis. Obes Surg 2013;23(7):980-986.
27. Goitein D, Feigin A, Segal-Lieberman G, et al. Laparoscopic sleeve gastrectomy as a revisional option after gastric band failure. Surg Endosc 2011;25(8):2626-2630.
28. Overs SE, Freeman RA, Zarshenas N, et al. Food tolerance and gastrointestinal quality of life following three bariatric procedures: adjustable gastric banding, Rouxen-Y gastric bypass, and sleeve gastrectomy. Obes Surg 2012;22(4):536-543.
29. D'Hondt M, Vanneste S, Pottel H, et al. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 2011;25(8):2498-2504.
30. Leivonen MK, Juuti A, Jaser N, et al. Laparoscopic sleeve gastrectomy in patients over 59 years: early recovery and 12-month follow-up. Obes Surg 2011;21(8):1180-1187.
31. Ruiz-Tovar J, Oller I, Tomas A, et al. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients. Am Surg 2012;78(9):969-974.
32. Huang C-K, Goel R, Tai C-M, et al. Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech 2013;23(6):481-485.
33. Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg 2009;19(10):1341-1345.
34. De Paula AL, Stival AR, Halpern A, et al. Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg 2011;15(8):1344-1353.